Novel Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitor, showing a remarkably low toxicity both in vitro and in vivo and increasing the function of regulatory T cells (Tregs) at well-tolerated concentrations

Novel highly potent (EC 50 = 1.6 nM) aryl hydrocarbon receptor (AhR) agonist with high affinity (K i = 88 nM)

Novel degrader of CRABP proteins

Novel Potent and Selective A3 Antagonist

Unique topoisomerase inhibitor, showing significant growth-inhibitory effects against large-cell lung cancer (Lu-116) and gastric adenocarcinoma (St-4)

Distinct IKur blocker

Novel inhibitor of COX and neutrophil migration

Novel prodrug of potent IspH inhibitor, killing clinical isolates of several multidrug-resistant bacteria, including those from the genera Acinetobacter, Pseudomonas, Klebsiella, Enterobacter, Vibrio, Shigella, Salmonella, Yersinia, Mycobacterium and Baci

Biological Active Reagents

Inhibitor of the cellulose biosynthesis, inhibiting anisotropic cell expansion resulting in a severely swollen and stunted growth phenotype

Natural genistein derivetive with antibacterial and antifungal activities

P2X-purinoceptor antagonist

Natural antibacterial agent with cytotoxicity and hemolytic properties against a larger panel of Gram-negative bacteria

Natural essential oil, showing activity against T. muris

Potent inotropic agent, inhibiting both PDE3 and PDE4

Iminosugar, binding selectively to N370S glucocerebrosidase and restoring its correct conformation and, consequently, enhancing its activity

Novel osteoclastogenesis inhibitor, preventing ovariectomy-induced osteoporosis in ddY mice

Natural Stabilizer of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface

Selective thromboxane A2 (TXA2) synthase inhibitor

Neutral BBB crossing reactivator for acetylcholinesterase inhibited by paraoxon, also acting as anticonvulsant

Novel potent hA2BAR antagonist (Ki = 3.66 nM)

ET B receptor agonist, showing anti-apoptotic activity and protecting neural cells in rats with cerebral ischemia

Inhibitor of IRE1 endoribonuclease activity, strongly inhibiting XBP-1 splicing in an in vivo model of acute endoplasmic reticulum stress.

Novel inhibitor of CDC25 phosphatases, actively against human cancer cells

Novel Orally Efficacious IRAK4 Inhibitor, Targeting MyD88L265P Mutant Diffuse Large B Cell Lymphoma

Novel potent and selective degrader of IRAK3, inducing proteasome-dependent degradation of IRAK3 and showing both CRBN and IRAK3 binding for activity

Novel interleukin-1 (IL-I) receptor-associated kinase (IRAK) modulator

NIR-II cyanine dye for cancer treatment and diagnosis

Novel potent inverse agonist of the chemokine receptor CXCR4, preventing CXCL12-mediated chemotaxis and triggering apoptosis in a panel of 18 cell lines and primary cultures, with superior mobilizing properties in vivo

Sulfasalazine analog, releasing 5-aminosalicylic acid and a nontoxic carrier molecule in the gastrointestinal tract